HealthQuill COVID-19
An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said.
Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

Read More
The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients return to normal activities if they are free of fever for at least 24 hours.
Drugs Health Pharma

CDC revises isolation guidance for Covid-19 patients in the US

HQ Team March 2, 2024: The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients.

Read More
About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.
Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC 

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

Read More
Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and organic sales growth.
Drugs Health Pharma

Moderna expects to break even in 2026, says CEO Stéphane Bancel

HQ Team January 5, 2023: Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and.

Read More
Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.
Drugs Health Pharma

Opinion: Covid-19 variant needs cautious vigilance, not undue panic

By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in.

Read More
Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study finds.
Drugs Health Pharma

Human lipid particles may be hidden reservoirs of Covid-19 virus

HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of.

Read More
Mosquitoes by the evening. Image Credit: Wolfgang Hasselmann on Unsplash
Climate Drugs Pharma

WHO global malaria strategy ‘off track by a wide margin’

HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.

Read More
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

Read More
One in seven people in the US has had long Covid by the end of 2022, according to a study by British and American researchers.
Drugs Health Pharma

One in seven people in US reports having long Covid by the end of 2022

HQ Team November 6, 2023: One in seven people in the US has had long Covid by the end of 2022, according to.

Read More